Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression

International Journal of Molecular Medicine

Volumn 29, Issue 5, 2012, Pages 855-863

  Yan, Meng Yi ^a   Chien, Su Yu ^a   Kuo, Shou Jen ^a   Chen, Dar Ren ^a   Su, Chin Cheng ^a,b,c  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b MINGDAO UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

BT 20 cells; Endoplasmic reticulum stress; MAPK; Tanshinone IIA

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BETA ACTIN; CALRETICULIN; CASPASE 12; CASPASE 3; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL XL; TANSHINONE IIA;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL VIABILITY; CYTOTOXICITY; DRUG ACTIVITY; ENDOPLASMIC RETICULUM STRESS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CASPASE 12; CELL LINE, TUMOR; CELL PROLIFERATION; DITERPENES, ABIETANE; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TRANSCRIPTION FACTOR CHOP; UP-REGULATION;

EID: 84863281854     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.908     Document Type: Article

References (29)

1. Lin TJ: Antioxidation mechanism of schizandrin and tanshinonatic acid A and their effects on the protection of cardio-toxic action of adriamycin. Sheng Li Ke Xue Jin Zhan 22: 342-345, 1991 (In Chinese).
2. Wang AM, Sha SH, Lesniak W and Schacht J: Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother 47: 1836-1841, 2003. (Pubitemid 36637803)
3. Lin R, Wang WR, Liu JT, Yang GD and Han CJ: Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. J Ethnopharmacol 108: 217-222, 2006. (Pubitemid 44635028)
4. Liang Y, Yang YM and Yuan SL: Studies on Pharmic mechanism and clinic application of tanshinone. Traditional Herbal Drugs 31: 304-306, 2000.
5. Jang SI, Kim HJ, Kim YJ, Jeong SI and You YO: Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacol 542: 1-7, 2006.
6. Li W, Li J, Ashok M, Wu R, Chen D, Yang L, et al: A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. J Immunol 78: 3856-3864, 2007. (Pubitemid 46417655)
7. Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF and Zhang J: Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells. World J Gastroenterol 10: 2024-2028, 2004. (Pubitemid 39106951)
8. Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang J, et al: Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer 116: 799-807, 2005. (Pubitemid 41099713)
9. Liu JJ, Lin DJ, Liu PQ, Huang M, Li XD, Huang RW: Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro. J Biomed Sci 13: 813-823, 2006. (Pubitemid 44900653)
10. Su CC and Lin YH: Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios. Int J Mol Med 22: 357-361, 2008.
11. Su CC and Lin YH: Tanshinone IIA downregulates the protein expression of ErbB-2 and upregulates TNF-α in colon cancer cells in vitro and in vivo. Int J Mol Med 22: 847-851, 2008.
12. Su CC, Chen GW, Kang JC and Chan MH: Growth inhibition and apoptosis induction by tanshinone IIA in human colon adenocarcinoma cells. Planta Med 74: 1357-1362, 2008.
13. Cheng CY and Su CC: Tanshinone IIA may inhibit the growth of small cell lung cancer H146 cells by upregulating the Bax/Bcl-2 ratio and decreasing mitochondrial membrane potential. Mol Med Rep 3: 645-650, 2010.
14. Chiu TL and Su CC: Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential. Int J Mol Med 25: 231-236, 2010.
15. Cheng CY and Su CC: Tanshinone IIA inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression. Int J Mol Med 26: 379-385, 2010.
16. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 1-22, 2011.
17. Lu Q, Zhang P, Zhang X and Chen J: Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer. Int J Mol Med 24: 773-780, 2009.
18. Zhang PR and Lü Q: A study on anticancer activity of tanshinone IIA against human breast cancer. Sichuan Da Xue Xue Bao Yi Xue Ban Mar 40: 245-249, 2009 (In Chinese).
19. Zhang X, Zhang PR, Chen J and Lü Q: A study on the effect of Tanshinone II A against human breast cancer in vivo. Sichuan Da Xue Xue Bao Yi Xue Ban 41: 62-67, 2010 (In Chinese).
20. Chen YL, Jian MH, Lin CC, Kang JC, Chen SP, Lin PC, Hung PJ, Chen JR, Chang WL, Lin SZ and Harn HJ: The induction of orphan nuclear receptor Nur77 expression by n-butylenephthalide as pharmaceuticals on hepatocellular carcinoma cell therapy. Mol Pharmacol 74: 1046-1058, 2008.
21. Su CC, Chen GW and Lin JG: Growth inhibition and apoptosis induction by tanshinone I in human colon cancer Colo 205 cells.Int J Mol Med 22: 613-618, 2008.
22. Chan SE, Lai HW, Su CC, Kuo SJ, Chien SY, Lin HY and Chen DR: Effect of supplementation of tanshinone IIA and sodium tanshinone IIA sulfonate on the anticancer effect of epirubicin: an in vitro study. Evid Based Complement Alternat Med 2011: 841564, 2011.
23. Mossman T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
24. Ma Y and Hendershot LM: The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 4: 966-977, 2004. (Pubitemid 39626220)
25. Kim R, Emi M, Tanabe K and Murakami S: Role of the unfolded protein response in cell death. Apoptosis 11: 5-13, 2006. (Pubitemid 43151639)
26. Rasheva VI and Domingos PM: Cellular responses to endoplasmic reticulum stress and apoptosis. Apoptosis 14: 996-1007, 2009.
27. Kim SM, Park HS, Jun DY, Woo HJ, Woo MH, Yang CH and Kim YH: Mollugin induces apoptosis in human Jurkat T cells through endoplasmic reticulum stress-mediated activation of JNK and caspase-12 and subsequent activation of mitochondria-dependent caspase cascade regulated by Bcl-xL. Toxicol Appl Pharmacol 241: 210-220, 2009.
28. Wagner EF and Nebreda AR: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549, 2009.
29. Jin UH, Suh SJ, Chang HW, Son JK, Lee SH, Son KH, Chang YC and Kim CH: Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP-9 activity through AKT signalingpathway. J Cell Biochem 104: 15-26, 2008.